<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">glaucoma</journal-id><journal-title-group><journal-title xml:lang="ru">Национальный журнал Глаукома</journal-title><trans-title-group xml:lang="en"><trans-title>National Journal glaucoma</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-4104</issn><issn pub-type="epub">2311-6862</issn><publisher><publisher-name>Federal State Budgetary Institution of Science “Krasnov Research Institute of Eye Diseases”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.53432/2078-4104-2025-24-2-84-92</article-id><article-id custom-type="elpub" pub-id-type="custom">glaucoma-567</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LITERATURE REVIEWS</subject></subj-group></article-categories><title-group><article-title>Проблема избыточного рубцевания в хирургии глауком. Часть 1: Современные представления о раневом процессе при антиглаукомных операциях</article-title><trans-title-group xml:lang="en"><trans-title>Excessive scarring in glaucoma surgery. Part 1: Current concepts of wound healing in glaucoma surgery</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4043-456X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юсеф</surname><given-names>Ю. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Yusef</surname><given-names>Yu. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., директор институт</p><p>119021, Москва, ул. Россолимо, 11А</p><p> </p></bio><bio xml:lang="en"><p>Dr. Sci. (Med.), Director</p><p>11A Rossolimo St., Moscow, 1190214</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5171-8261</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Антонов</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Antonov</surname><given-names>А. А.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., заведующий отделом глаукомы</p><p>119021, Москва, ул. Россолимо, 11А</p></bio><bio xml:lang="en"><p>Dr. Sci. (Med.), Head of the Department of Glaucoma</p><p>11A Rossolimo St., Moscow, 1190214</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8258-6011</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Суббот</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Subbot</surname><given-names>А. М.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., старший научный сотрудник, и.о. заведующего лаборатории фундаментальных исследований в офтальмологии</p><p>119021, Москва, ул. Россолимо, 11А</p></bio><bio xml:lang="en"><p>Cand. Sci. (Med.), senior researcher, acting Head of the Laboratory of Fundamental Research in Ophthalmology</p><p>11A Rossolimo St., Moscow, 1190214</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2893-0173</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Виткова</surname><given-names>И. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Vitkova</surname><given-names>I. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант</p><p>119021, Москва, ул. Россолимо, 11А</p></bio><bio xml:lang="en"><p>postgraduate student</p><p>11A Rossolimo St., Moscow, 1190214</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-4800-870X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Емец</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Emets</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>младший научный сотрудник лаборатории фундаментальных исследований в офтальмологии</p><p>119021, Москва, ул. Россолимо, 11А</p></bio><bio xml:lang="en"><p>junior researcher at the Laboratory of Fundamental Research in Ophthalmology</p><p>11A Rossolimo St., Moscow, 1190214</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7735-9650</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Витков</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vitkov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Виткова Ирина Ильинична, младший научный сотрудник отдела глаукомы</p><p>119021, Москва, ул. Россолимо, 11А</p></bio><bio xml:lang="en"><p> junior researcher at the Department of Glaucoma</p><p>11A Rossolimo St., Moscow, 1190214</p></bio><email xlink:type="simple">ivitkova.niigb@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-5416-2063</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семенов</surname><given-names>Е. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Semenov</surname><given-names>E. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант</p><p>119021, Москва, ул. Россолимо, 11А</p></bio><bio xml:lang="en"><p>postgraduate student</p><p>11A Rossolimo St., Moscow, 1190214</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «НИИГБ им. М.М. Краснова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Krasnov Research Institute of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>27</day><month>05</month><year>2025</year></pub-date><volume>24</volume><issue>2</issue><fpage>84</fpage><lpage>92</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Юсеф Ю.Н., Антонов А.А., Суббот А.М., Виткова И.И., Емец Е.В., Витков А.А., Семенов Е.Д., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Юсеф Ю.Н., Антонов А.А., Суббот А.М., Виткова И.И., Емец Е.В., Витков А.А., Семенов Е.Д.</copyright-holder><copyright-holder xml:lang="en">Yusef Y.N., Antonov А.А., Subbot А.М., Vitkova I.I., Emets E.V., Vitkov A.A., Semenov E.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.glaucomajournal.ru/jour/article/view/567">https://www.glaucomajournal.ru/jour/article/view/567</self-uri><abstract><p>Основным осложнением хирургии глаукомы является рубцовое изменение вновь сформированных путей оттока. Этот процесс приводит к повторному повышению внутриглазного давления и является причиной снижения эффективности антиглаукомных операций. В каскаде последовательно проходящих этапов заживления хирургической раны наиболее важной считается фаза воспаления. Уменьшение ее выраженности и длительности является основной целью послеоперационной терапии, так как избыточное воспаление приводит к образованию рубцовых тканей. В свою очередь, его чрезмерное подавление приводит к развитию «неэффективного разрешения». В этом случае воспаление становится хроническим, а следующая фаза заживления не наступает. Для полного восстановления архитектоники поврежденных тканей процесс заживления должен последовательно пройти все фазы. Корректному завершению воспаления может способствовать использование про-разрешающих медиаторов.</p><p>В обзоре исследуются физиологические процессы восстановления архитектоники поврежденных тканей и причины возникновения рубцовых изменений во вновь сформированных путях оттока внутриглазной жидкости.</p></abstract><trans-abstract xml:lang="en"><p>The main complication of glaucoma surgery is cicatricial changes in newly formed outflow tracts. This process leads to a repeated increase in intraocular pressure (IOP) and is the reason for a decrease in the effectiveness of glaucoma surgeries. In the cascade of successive stages of surgical wound healing, the inflammation phase is considered the most important. Reducing its severity and duration is the main goal of postoperative therapy, since excessive inflammation leads to the formation of scar tissues. In turn, its excessive suppression leads to the development of "ineffective resolution". In this case, the inflammation becomes chronic, and the next healing phase does not occur. For complete restoration of the damaged tissue architecture, the healing process must consistently go through all phases. The use of pro-resolving mediators can contribute to the correct completion of inflammation.</p><p>This review explores the physiological processes of restoration of the damaged tissue architecture, as well as the causes of cicatricial changes in the newly formed intraocular fluid outflow tracts.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>глаукома</kwd><kwd>хирургия глаукомы</kwd><kwd>фиброз</kwd><kwd>внутриглазное давление</kwd></kwd-group><kwd-group xml:lang="en"><kwd>glaucoma</kwd><kwd>glaucoma surgery</kwd><kwd>fibrosis</kwd><kwd>intraocular pressure</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">авторы не получали финансирование при проведении исследования и написании статьи</funding-statement><funding-statement xml:lang="en">the authors received no specific funding for this work</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Антонов А.А., Карлова Е.В., Брежнев А.Ю., Дорофеев Д.А. Современное состояние офтальмотонометрии. Вестник офтальмологии 2020; 136(6):100-107. https://doi.org/10.17116/oftalma2020136061100</mixed-citation><mixed-citation xml:lang="en">Antonov A.A., Karlova E.V., Brezhnev A.Yu., Dorofeev D.A. Current state of ophthalmic tonometry. Russian Annals of Ophthalmology 2020; 136(6):100-107. https://doi.org/10.17116/oftalma2020136061100</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Le A, Mukesh BN, McCarty CA, Taylor HR. Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci 2003; 44(9):3783-3789. https://doi.org/10.1167/iovs.03-0077</mixed-citation><mixed-citation xml:lang="en">Le A, Mukesh BN, McCarty CA, Taylor HR. Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci 2003; 44(9):3783-3789. https://doi.org/10.1167/iovs.03-0077</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Czudowska MA, Ramdas WD, Wolfs RC, Hofman A, De Jong PT, Vingerling JR, Jansonius NM. Incidence of glaucomatous visual field loss: a ten-year follow-up from the Rotterdam Study. Ophthalmology 2010; 117(9):1705-1712. https://doi.org/10.1016/j.ophtha.2010.01.034</mixed-citation><mixed-citation xml:lang="en">Czudowska MA, Ramdas WD, Wolfs RC, Hofman A, De Jong PT, Vingerling JR, Jansonius NM. Incidence of glaucomatous visual field loss: a ten-year follow-up from the Rotterdam Study. Ophthalmology 2010; 117(9):1705-1712. https://doi.org/10.1016/j.ophtha.2010.01.034</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Nemesure B, Honkanen R, Hennis A, Wu SY, Leske MC; Barbados Eye Studies Group. Incident open-angle glaucoma and intraocular pressure. Ophthalmology. 2007; 114(10):1810-1815. https://doi.org/10.1016/j.ophtha.2007.04.003</mixed-citation><mixed-citation xml:lang="en">Nemesure B, Honkanen R, Hennis A, Wu SY, Leske MC; Barbados Eye Studies Group. Incident open-angle glaucoma and intraocular pressure. Ophthalmology. 2007; 114(10):1810-1815. https://doi.org/10.1016/j.ophtha.2007.04.003</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Еричев В.П., Витков А.А. Топические бета-блокаторы: взаимодействие и нежелательные явления (аналитический обзор). XVIII Всероссийская школа офтальмолога 2019; 37-45. https://doi.org/10.30808/978-5-6040782-2019-1-1-37-44</mixed-citation><mixed-citation xml:lang="en">Erichev VP, Vitkov AA. Topical beta blockers: interaction and undesirable effects (analytical review). XVIII All-Russian Ophthalmology school 2019; 37-45. https://doi.org/10.30808/978-5-6040782-2019-1-1-37-44</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Антонов А.А., Витков А.А., Агаджанян Т.М. Эффективность и безопасность отечественного дженерика травопроста в различных режимах терапии первичной открытоугольной глаукомы. Национальный журнал глаукома. 2021; 20(4):50-56. https://doi.org/10.53432/2078-4104-2021-20-4-50-56</mixed-citation><mixed-citation xml:lang="en">Antonov A.A., Vitkov A.A., Agadzhanyan T.M. The efficacy and safety of the domestic travoprost generic in various modes of therapy for primary open-angle glaucoma. National Journal glaucoma 2021; 20(4): 50-56. https://doi.org/10.53432/2078-4104-2021-20-4-50-56</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Еричев В.П., Басинский С.Н., Куроедов А.В. О переходе к хирургическому этапу лечения глаукомы. Национальный журнал глаукома 2023; 22(1):92-102. https://doi.org/10.53432/2078-4104-2023-22-1-92-102.</mixed-citation><mixed-citation xml:lang="en">Erichev V.P., Basinsky S.N., Kuroyedov A.V. Moving on to surgical stage of glaucoma treatment. National Journal glaucoma 2023; 22(1): 92-102. https://doi.org/10.53432/2078-4104-2023-22-1-92-102</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Петров С.Ю., Ловпаче Дж.Н., Лоскутов И.А., Сафонова Д.М. Влияние местной гипотензивной терапии на состояние тканей переднего отрезка глаза и исход фистулизирующей хирургии глауком. Офтальмологические ведомости. 2017; 10(4):41-47. https://doi.org/10.17816/OV10441-47</mixed-citation><mixed-citation xml:lang="en">Petrov S.Yu., Lovpache Dzh.N., Loskutov I.A., Safronova D.M. The influence of local IOP-lowering therapy on the anterior segment tissues and outcome of glaucoma filtering surgery. Oftalmologičeskie vedomosti 2017; 10(4):41-47. https://doi.org/10.17816/OV10441-47</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Мельник М.А., Мамиконян В.Р., Шмелева-Кенуфи О.А., Муха А.И. Гипотензивное лечение глаукомы — малоинвазивная хирургия. Обзор литературы. Офтальмология 2022; 19(1):5-14. https://doi.org/10.18008/1816-5095-2022-1-5-14</mixed-citation><mixed-citation xml:lang="en">Melnik M.A., Mamikonyan V.R., Shmeleva-Kenoufi O.A., Mukha A.I. Hypotensive Treatment of Glaucoma — Minimally Invasive Surgery. Literature review. Ophthalmology in Russia 2022; 19(1):5-14. https://doi.org/10.18008/1816-5095-2022-1-5-14</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Христин М., Еричев В.П., Анисимова С.Ю., Анисимов С.И. Комбинированная система профилактики избыточного рубцевания в хирургии глаукомы. Глаукома 2010; 2:16-18.</mixed-citation><mixed-citation xml:lang="en">Hristin M., Erichev V.P., Anisimova S.Yu., Anisimov S.I. Combined system of excessive scarring prevention in glaucoma surgery. Glauсoma 2010; 2:16-18.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Еричев В.П., Хачатрян Г.К. Гликозаминогликановый матрикс в профилактике конъюнктивально-склерального рубцевания при синустрабекулэктомии. Национальный журнал глаукома 2018; 17(1):37-42. https://doi.org/10.25700/NJG.2018.01.04</mixed-citation><mixed-citation xml:lang="en">Erichev V.P., Khachatryan G.K. Glycosaminoglycan matrix in the prevention of conjunctival scleral scarring with sinustrabeculectomy. National Journal glaucoma 2018; 17(1):37-42. https://doi.org/10.25700/NJG.2018.01.04</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Волкова Н.В., Юрьева Т.Н., Куроедов А.В. Анализ эффективности и безопасности имплантации дренажных устройств в хирургии глаукомы. Национальный журнал глаукома 2024; 23(2):79-94. https://doi.org/10.53432/2078-4104-2024-23-2-79-94</mixed-citation><mixed-citation xml:lang="en">Volkova N.V., Iureva T.N., Kuroyedov A.V. Analysis of the effectiveness and safety of implantation of drainage devices in glaucoma surgery. National Journal glaucoma. 2024; 23(2):79-94. https://doi.org/10.53432/2078-4104-2024-23-2-79-94</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Егоров Е.А., Куроедов А.В., Городничий В.В. и др. Ранние и отдаленные результаты хирургического лечения глаукомы (результаты многоцентрового исследования стран СНГ). РМЖ Клиническая офтальмология 2017; 1:25-34. https://doi.org/10.21689/2311-7729-2017-17-1-25-34</mixed-citation><mixed-citation xml:lang="en">Egorov E.A., Kuroyedov A.V., Gorodnichiy V.V. et al. Early and longterm outcomes of glaucoma surgery the results of multicenter study in CIS countries. RMJ Clinical Ophthalmology 2017; 1:25-34. https://doi.org/10.21689/2311-7729-2017-17-1-25-34</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Сулейман Е.А., Петров С.Ю. Новые методики синустрабекулэктомии с пролонгированным гипотензивным эффектом. Российский офтальмологический журнал 2022; 15(3):61-66. https://doi.org/10.21516/2072-0076-2022-15-3-61-66</mixed-citation><mixed-citation xml:lang="en">Suleiman E.A., Petrov S.Yu. New techniques of sinus trabeculectomy with prolonged hypotensive effect. Russian Ophthalmological Journal 2022; 15(3):61-66. https://doi.org/10.21516/2072-0076-2022-15-3-61-66</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Петров С.Ю., Сафонова Д.М. Современная концепция избыточного рубцевания в хирургии глаукомы. Офтальмология 2015; 12(4):9-16. https://doi.org/10.18008/1816-5095-2015-4-9-17</mixed-citation><mixed-citation xml:lang="en">Petrov S.Yu., Safonova D.M. The modern concept of wound healing in glaucoma surgery. Ophthalmology in Russia 2015; 12(4):9-16. https://doi.org/10.18008/1816-5095-2015-4-9-17</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Петров С.Ю. Современная концепция борьбы с избыточным рубцеванием после фистулизирующей хирургии глаукомы. Противовоспалительные препараты и новые тенденции. Офтальмология. 2017; 14(2):99-105. https://doi.org/10.18008/1816-5095-2017-1-5-11</mixed-citation><mixed-citation xml:lang="en">Petrov S.Ju. Modern concept of fight against excessive scarring after fistulizing glaucoma surgery. Anti-inflammatory drugs and new trends. Ophthalmology in Russia 2017; 14(2):99–105. https://doi.org/10.18008/1816-5095-2017-1-5-11</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Захидов А.Б., Селезнев А.В., Газизова И.Р. и др. Интраоперационное применение антиметаболитов в хирургии глаукомы. Национальный журнал глаукома 2020; 19(1):40-45. https://doi.org/10.25700/NJG.2020.01.06</mixed-citation><mixed-citation xml:lang="en">Zahidov A.B., Seleznev A.V., Gazizova I.R., Kuroyedov A.V. et al. Intraoperative use of antimetabolites in glaucoma surgery. National Journal glaucoma 2020; 19(1):40-45. https://doi.org/10.25700/NJG.2020.01.06</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Мамиконян В.Р., Петров С.Ю., Сафонова Д.М. Ингибиторы VEGF в глаукомной хирургии. Офтальмологические ведомости 2016; 9(1):47-55.</mixed-citation><mixed-citation xml:lang="en">Mamikonjan V.R., Petrov S.Ju., Safonova D.M. VEGF inhibitors in glaucoma surgery. Oftalmologičeskie vedomosti 2016; 9(1):47-55.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Петров С.Ю. Принципы современной хирургии глаукомы согласно IV изданию Европейского глаукомного руководства (аналитический комментарий). РМЖ Клиническая офтальмология 2017; 17(3):184-189. https://doi.org/10.21689/2311-7729-2017-17-3-184-189</mixed-citation><mixed-citation xml:lang="en">Petrov S.Yu. Principles of modern incisional surgery for glaucoma by the 4th Edition of the Terminology and Guidelines for Glaucoma of the European Glaucoma Society. RMJ Clinical Ophthalmology 2017; 17(3):184-189. https://doi.org/10.21689/2311-7729-2017-17-3-184-189</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J 2004; 18(7):816-827. https://doi.org/10.1096/fj.03-1273rev</mixed-citation><mixed-citation xml:lang="en">Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J 2004; 18(7):816-827. https://doi.org/10.1096/fj.03-1273rev</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Юрьева Т.Н., Малышева Ю.В. Особенности репаративного процесса после антиглаукомной хирургии. Национальный журнал глаукома 2023; 22(4):89-98. https://doi.org/10.53432/2078-4104-2023-22-4-89-98</mixed-citation><mixed-citation xml:lang="en">Iureva T.N., Malisheva Yu.V. Features of the reparative process after antiglaucoma surgery. National Journal glaucoma. 2023; 22(4):89-98. https://doi.org/10.53432/2078-4104-2023-22-4-89-98</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Малюгин Б.Э., Сидорова А.В., Старостина А.В., и др. Фармакотерапевтические подходы к управлению репаративными процессами в хирургии глаукомы. Вестник офтальмологии 2022; 138(4):136-143. https://doi.org/10.17116/oftalma2022138041136</mixed-citation><mixed-citation xml:lang="en">Malyugin BE, Sidorova AV, Starostina AV, Zhuravlev AS, Khaletskaya AA, Eliseeva MA, Smirnova EA. Pharmacological modulation of wound healing in glaucoma surgery. Vestn Oftalmol 2022; 138(4): 136-143. https://doi.org/10.17116/oftalma2022138041136.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Gualdi G, Costantini E, Reale M, Amerio P. Wound Repair and Extremely Low Frequency-Electromagnetic Field: Insight from In Vitro Study and Potential Clinical Application. Int J Mol Sci 2021; 22(9):5037. https://doi.org/10.3390/ijms22095037</mixed-citation><mixed-citation xml:lang="en">Gualdi G, Costantini E, Reale M, Amerio P. Wound Repair and Extremely Low Frequency-Electromagnetic Field: Insight from In Vitro Study and Potential Clinical Application. Int J Mol Sci 2021; 22(9):5037. https://doi.org/10.3390/ijms22095037</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Shaw TJ, Martin P. Wound repair at a glance. J Cell Sci 2009; 122(Pt 18):3209-13. https://doi.org/10.1242/jcs.031187</mixed-citation><mixed-citation xml:lang="en">Shaw TJ, Martin P. Wound repair at a glance. J Cell Sci 2009; 122(Pt 18):3209-13. https://doi.org/10.1242/jcs.031187</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Gonzalez AC, Costa TF, Andrade ZA, Medrado AR. Wound healing — A literature review. An Bras Dermatol 2016; 91(5):614-620. https://doi.org/10.1590/abd1806-4841.20164741</mixed-citation><mixed-citation xml:lang="en">Gonzalez AC, Costa TF, Andrade ZA, Medrado AR. Wound healing — A literature review. An Bras Dermatol 2016; 91(5):614-620. https://doi.org/10.1590/abd1806-4841.20164741</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Zada M, Pattamatta U, White A. Modulation of Fibroblasts in Conjunctival Wound Healing. Ophthalmology 2018; 125(2):179-192. https://doi.org/10.1016/j.ophtha.2017.08.028</mixed-citation><mixed-citation xml:lang="en">Zada M, Pattamatta U, White A. Modulation of Fibroblasts in Conjunctival Wound Healing. Ophthalmology 2018; 125(2):179-192. https://doi.org/10.1016/j.ophtha.2017.08.028</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Mack M. Inflammation and fibrosis. Matrix Biol 2018; 68-69:106-121. https://doi.org/10.1016/j.matbio.2017.11.010</mixed-citation><mixed-citation xml:lang="en">Mack M. Inflammation and fibrosis. Matrix Biol 2018; 68-69:106-121. https://doi.org/10.1016/j.matbio.2017.11.010</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Dhall S, Wijesinghe DS, Karim ZA, Castro A, Vemana HP, Khasawneh FT, Chalfant CE, Martins-Green M. Arachidonic acid-derived signaling lipids and functions in impaired healing. Wound Repair Regen 2015; 23(5):644-656. https://doi.org/10.1111/wrr.12337.</mixed-citation><mixed-citation xml:lang="en">Dhall S, Wijesinghe DS, Karim ZA, Castro A, Vemana HP, Khasawneh FT, Chalfant CE, Martins-Green M. Arachidonic acid-derived signaling lipids and functions in impaired healing. Wound Repair Regen 2015; 23(5):644-656. https://doi.org/10.1111/wrr.12337.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Bautista-Hernández LA, Gómez-Olivares JL, Buentello-Volante B, Bautista-de Lucio VM. Fibroblasts: The Unknown Sentinels Eliciting Immune Responses Against Microorganisms. Eur J Microbiol Immunol (Bp) 2017; 7(3):151-157. https://doi.org/10.1556/1886.2017.00009.</mixed-citation><mixed-citation xml:lang="en">Bautista-Hernández LA, Gómez-Olivares JL, Buentello-Volante B, Bautista-de Lucio VM. Fibroblasts: The Unknown Sentinels Eliciting Immune Responses Against Microorganisms. Eur J Microbiol Immunol (Bp) 2017; 7(3):151-157. https://doi.org/10.1556/1886.2017.00009.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Sunkari VG, Aranovitch B, Portwood N, Nikoshkov A. Effects of a lowintensity electromagnetic field on fibroblast migration and proliferation. Electromagn Biol Med 2011; 30(2):80-85. https://doi.org/10.3109/15368378.2011.566774</mixed-citation><mixed-citation xml:lang="en">Sunkari VG, Aranovitch B, Portwood N, Nikoshkov A. Effects of a lowintensity electromagnetic field on fibroblast migration and proliferation. Electromagn Biol Med 2011; 30(2):80-85. https://doi.org/10.3109/15368378.2011.566774</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Shu DY, Lovicu FJ. Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis. Prog Retin Eye Res 2017; 60: 44-65. https://doi.org/10.1016/j.preteyeres.2017.08.001.</mixed-citation><mixed-citation xml:lang="en">Shu DY, Lovicu FJ. Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis. Prog Retin Eye Res 2017; 60: 44-65. https://doi.org/10.1016/j.preteyeres.2017.08.001.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">de la Rosa X, Norris PC, Chiang N, Rodriguez AR, Spur BW, Serhan CN. Identification and Complete Stereochemical Assignments of the New Resolvin Conjugates in Tissue Regeneration in Human Tissues that Stimulate Proresolving Phagocyte Functions and Tissue Regeneration. Am J Pathol 2018; 188(4):950-966. https://doi.org/10.1016/j.ajpath.2018.01.004</mixed-citation><mixed-citation xml:lang="en">de la Rosa X, Norris PC, Chiang N, Rodriguez AR, Spur BW, Serhan CN. Identification and Complete Stereochemical Assignments of the New Resolvin Conjugates in Tissue Regeneration in Human Tissues that Stimulate Proresolving Phagocyte Functions and Tissue Regeneration. Am J Pathol 2018; 188(4):950-966. https://doi.org/10.1016/j.ajpath.2018.01.004</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Krönke G, Reich N, Scholtysek C, Akhmetshina A, Uderhardt S, Zerr P, Palumbo K, Lang V, Dees C, Distler O, Schett G, Distler JH. The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis. Ann Rheum Dis 2012; 71(6):1081-1087. https://doi.org/10.1136/annrheumdis-2011-200745</mixed-citation><mixed-citation xml:lang="en">Krönke G, Reich N, Scholtysek C, Akhmetshina A, Uderhardt S, Zerr P, Palumbo K, Lang V, Dees C, Distler O, Schett G, Distler JH. The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis. Ann Rheum Dis 2012; 71(6):1081-1087. https://doi.org/10.1136/annrheumdis-2011-200745</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Qu X, Zhang X, Yao J, Song J, Nikolic-Paterson DJ, Li J. Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation. J Pathol 2012; 228(4):506-519. https://doi.org/10.1002/path.4050</mixed-citation><mixed-citation xml:lang="en">Qu X, Zhang X, Yao J, Song J, Nikolic-Paterson DJ, Li J. Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation. J Pathol 2012; 228(4):506-519. https://doi.org/10.1002/path.4050</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng S, Wang Q, D'Souza V, Bartis D, Dancer R, Parekh D, Gao F, Lian Q, Jin S, Thickett DR. ResolvinD1 stimulates epithelial wound repair and inhibits TGF-β-induced EMT whilst reducing fibroproliferation and collagen production. Lab Invest 2018; 98(1):130-140. https://doi.org/10.1038/labinvest.2017.114.</mixed-citation><mixed-citation xml:lang="en">Zheng S, Wang Q, D'Souza V, Bartis D, Dancer R, Parekh D, Gao F, Lian Q, Jin S, Thickett DR. ResolvinD1 stimulates epithelial wound repair and inhibits TGF-β-induced EMT whilst reducing fibroproliferation and collagen production. Lab Invest 2018; 98(1):130-140. https://doi.org/10.1038/labinvest.2017.114.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Perretti M, Leroy X, Bland EJ, Montero-Melendez T. Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation. Trends Pharmacol Sci. 2015; 36(11):737-755. https://doi.org/10.1016/j.tips.2015.07.007</mixed-citation><mixed-citation xml:lang="en">Perretti M, Leroy X, Bland EJ, Montero-Melendez T. Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation. Trends Pharmacol Sci. 2015; 36(11):737-755. https://doi.org/10.1016/j.tips.2015.07.007</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Hinz B. Myofibroblasts. Exp Eye Res. 2016; 142:56-70. https://doi.org/10.1016/j.exer.2015.07.009.</mixed-citation><mixed-citation xml:lang="en">Hinz B. Myofibroblasts. Exp Eye Res. 2016; 142:56-70. https://doi.org/10.1016/j.exer.2015.07.009.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Paul Ehrlich H, Sun B, Kainth KS, Kromah F. Elucidating the mechanism of wound contraction: rapid versus sustained myosin ATPase activity in attached-delayed-released compared with free-floating fibroblast-populated collagen lattices. Wound Repair Regen. 2006; 14(5):625-632. https://doi.org/10.1111/j.1743-6109.2006.00170.x</mixed-citation><mixed-citation xml:lang="en">Paul Ehrlich H, Sun B, Kainth KS, Kromah F. Elucidating the mechanism of wound contraction: rapid versus sustained myosin ATPase activity in attached-delayed-released compared with free-floating fibroblast-populated collagen lattices. Wound Repair Regen. 2006; 14(5):625-632. https://doi.org/10.1111/j.1743-6109.2006.00170.x</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Hinz B. The myofibroblast: paradigm for a mechanically active cell. J Biomech. 2010; 43(1):146-155. https://doi.org/10.1016/j.jbiomech.2009.09.020</mixed-citation><mixed-citation xml:lang="en">Hinz B. The myofibroblast: paradigm for a mechanically active cell. J Biomech. 2010; 43(1):146-155. https://doi.org/10.1016/j.jbiomech.2009.09.020</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 2012; 18(7):1028-1040. https://doi.org/10.1038/nm.2807.</mixed-citation><mixed-citation xml:lang="en">Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 2012; 18(7):1028-1040. https://doi.org/10.1038/nm.2807.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Recchiuti A, Serhan CN. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. Front Immunol 2012; 3:298. https://doi.org/10.3389/fimmu.2012.00298</mixed-citation><mixed-citation xml:lang="en">Recchiuti A, Serhan CN. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. Front Immunol 2012; 3:298. https://doi.org/10.3389/fimmu.2012.00298</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Wang PH, Huang BS, Horng HC, Yeh CC, Chen YJ. Wound healing. J Chin Med Assoc 2018; 81(2):94-101. https://doi.org/10.1016/j.jcma.2017.11.002</mixed-citation><mixed-citation xml:lang="en">Wang PH, Huang BS, Horng HC, Yeh CC, Chen YJ. Wound healing. J Chin Med Assoc 2018; 81(2):94-101. https://doi.org/10.1016/j.jcma.2017.11.002</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
